4//SEC Filing
BIOGEN IDEC INC 4
Accession 0001209191-05-050504
$BIIBCIK 0000875045operating
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:26 PM ET
Size
36.9 KB
Accession
0001209191-05-050504
Insider Transaction Report
Form 4
BIOGEN IDEC INCBIIB
KELLER THOMAS F
Director
Transactions
- Sale
Common Stock
2005-10-01$39.00/sh−200$7,800→ 20,250 total(indirect: Keller Bros. Investment LLP) - Sale
Common Stock
2005-10-01$39.02/sh−100$3,902→ 20,450 total(indirect: Keller Bros. Investment LLP) - Sale
Common Stock
2005-10-01$38.75/sh−600$23,250→ 18,350 total(indirect: Keller Bros. Investment LLP) - Sale
Common Stock
2005-10-01$38.70/sh−300$11,610→ 17,850 total(indirect: Keller Bros. Investment LLP) - Exercise/Conversion
Common Stock
2005-10-01$15.16/sh+10,350$156,906→ 27,600 total(indirect: Keller Bros. Investment LLP) - Exercise/Conversion
Stock Option (right-to-buy)
2005-10-01−10,350→ 17,250 total(indirect: Keller Bros. Investment LLP)Exercise: $15.16Exp: 2006-09-20→ Common Stock (10,350 underlying)
Holdings
- 920(indirect: Keller Bros. Investment LLP)
Common Stock
Footnotes (5)
- [F1]Options are held by a limited partnership of which the reporting person is a general partner.
- [F2]Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F3]Common stock held by a limited partnership of which the reporting person is a general partner.
- [F4]Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC rule 16(b)-3(d).
- [F5]The stock option became exerciseable in three (3) equal installments, commencing one year after the grant date of 09/20/96.
Documents
Issuer
BIOGEN IDEC INC
CIK 0000875045
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000875045
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 4:26 PM ET
- Size
- 36.9 KB